Medical Innovations
EDA, a novel delivery matrix for the safe delivery of enzymes and other active compounds to the gastrointestinal tract
This novel matrix is a hyaluronic acid-based, functionalized hydrogel. It is designed to work with Prolyl-endoproteases (PEPs), endoproteases (EPs) and other compounds, to protect them from being broken down in the stomach and to deliver them to the gastrointestinal tract for in their functional form for action and / or absorption.
Most enzymes are deactivated in the stomach and do not reach the small intestine. This novel matrix protects enzymes or other ‘carried’ compounds from the acidic conditions and the actions of digestive enzymes in the stomach, allowing them to reach their target delivery site – the small intestine – intact and active.
This novel matrix protects enzymes from the acidic conditions and the actions of digestive enzymes in the stomach, allowing them to reach their target delivery site – the small intestine – intact and active.